tetano
Editor, Senior Moderator
Eur Heart J Case Rep
. 2022 Jan 9;6(1):ytac004.
doi: 10.1093/ehjcr/ytac004. eCollection 2022 Jan.
A report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination
Christopher Paul Bengel[SUP] 1 [/SUP], Rifat Kacapor[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Vaccination is the most important measure to control the coronavirus disease 2019 (COVID-19) pandemic. Myocarditis has been reported as a rare adverse reaction to COVID-19 vaccines. The clinical presentation of myocarditis in such cases can range from mild general symptoms to acute heart failure.
Case summary: We report the cases of two young men who presented with chest pain and dyspnoea following the administration of the mRNA COVID-19 vaccine. Cardiac investigations revealed findings typical of acute myocarditis.
Discussion: Myocarditis is a rare complication following mRNA COVID-19 vaccination. In this case series, the temporal proximity of the development of acute myocarditis and the administration of the mRNA COVID-19 vaccine was acknowledged. In the absence of other causative factors, myocarditis in these patients potentially occurred due to an adverse reaction to the mRNA COVID-19 vaccine. However, a causal relationship remains speculative. Clinical suspicion of myocarditis should be high if patients present with chest pain or dyspnoea after receiving COVID-19 vaccination.
Keywords: Adverse reaction; COVID-19; Case report; Myocarditis; Vaccine.
. 2022 Jan 9;6(1):ytac004.
doi: 10.1093/ehjcr/ytac004. eCollection 2022 Jan.
A report of two cases of myocarditis following mRNA coronavirus disease 2019 vaccination
Christopher Paul Bengel[SUP] 1 [/SUP], Rifat Kacapor[SUP] 1 [/SUP]
Affiliations
- PMID: 35169677
- PMCID: PMC8755378
- DOI: 10.1093/ehjcr/ytac004
Abstract
Background: Vaccination is the most important measure to control the coronavirus disease 2019 (COVID-19) pandemic. Myocarditis has been reported as a rare adverse reaction to COVID-19 vaccines. The clinical presentation of myocarditis in such cases can range from mild general symptoms to acute heart failure.
Case summary: We report the cases of two young men who presented with chest pain and dyspnoea following the administration of the mRNA COVID-19 vaccine. Cardiac investigations revealed findings typical of acute myocarditis.
Discussion: Myocarditis is a rare complication following mRNA COVID-19 vaccination. In this case series, the temporal proximity of the development of acute myocarditis and the administration of the mRNA COVID-19 vaccine was acknowledged. In the absence of other causative factors, myocarditis in these patients potentially occurred due to an adverse reaction to the mRNA COVID-19 vaccine. However, a causal relationship remains speculative. Clinical suspicion of myocarditis should be high if patients present with chest pain or dyspnoea after receiving COVID-19 vaccination.
Keywords: Adverse reaction; COVID-19; Case report; Myocarditis; Vaccine.